130 related articles for article (PubMed ID: 11696568)
1. Chemokines and atherosclerosis: what Adam Smith has to say about vascular disease.
Rollins BJ
J Clin Invest; 2001 Nov; 108(9):1269-71. PubMed ID: 11696568
[No Abstract] [Full Text] [Related]
2. Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2.
Ringe J; Strassburg S; Neumann K; Endres M; Notter M; Burmester GR; Kaps C; Sittinger M
J Cell Biochem; 2007 May; 101(1):135-46. PubMed ID: 17295203
[TBL] [Abstract][Full Text] [Related]
3. Chemokines in the pathogenesis of vascular disease.
Charo IF; Taubman MB
Circ Res; 2004 Oct; 95(9):858-66. PubMed ID: 15514167
[TBL] [Abstract][Full Text] [Related]
4. The role of MCP-1 in atherosclerosis.
Harrington JR
Stem Cells; 2000; 18(1):65-6. PubMed ID: 10661575
[No Abstract] [Full Text] [Related]
5. In Vivo Models to Study Chemokine Biology.
Amaral FA; Boff D; Teixeira MM
Methods Enzymol; 2016; 570():261-80. PubMed ID: 26921950
[TBL] [Abstract][Full Text] [Related]
6. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis.
Boring L; Gosling J; Cleary M; Charo IF
Nature; 1998 Aug; 394(6696):894-7. PubMed ID: 9732872
[TBL] [Abstract][Full Text] [Related]
7. Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells.
Salcedo R; Resau JH; Halverson D; Hudson EA; Dambach M; Powell D; Wasserman K; Oppenheim JJ
FASEB J; 2000 Oct; 14(13):2055-64. PubMed ID: 11023990
[TBL] [Abstract][Full Text] [Related]
8. MCP-1 and CCR2 contribute to non-lymphocyte-mediated brain disease induced by Fr98 polytropic retrovirus infection in mice: role for astrocytes in retroviral neuropathogenesis.
Peterson KE; Errett JS; Wei T; Dimcheff DE; Ransohoff R; Kuziel WA; Evans L; Chesebro B
J Virol; 2004 Jun; 78(12):6449-58. PubMed ID: 15163738
[TBL] [Abstract][Full Text] [Related]
9. High level expression, activation, and antagonism of CC chemokine receptors CCR2 and CCR3 in Chinese hamster ovary cells.
Parody TR; Stone MJ
Cytokine; 2004 Jul; 27(1):38-46. PubMed ID: 15207250
[TBL] [Abstract][Full Text] [Related]
10. [Role of chemokines/chemokine receptors in pathogenesis of diabetic nephropathy].
Hara A; Wada T
Nihon Jinzo Gakkai Shi; 2011; 53(7):1027-33. PubMed ID: 22073868
[No Abstract] [Full Text] [Related]
11. Human monocyte-derived dendritic cells expressing both chemotactic cytokines IL-8, MCP-1, RANTES and their receptors, and their selective migration to these chemokines.
Zhu K; Shen Q; Ulrich M; Zheng M
Chin Med J (Engl); 2000 Dec; 113(12):1124-8. PubMed ID: 11776150
[TBL] [Abstract][Full Text] [Related]
12. New therapeutics that modulate chemokine networks.
Schwarz MK; Wells TN
Nat Rev Drug Discov; 2002 May; 1(5):347-58. PubMed ID: 12120410
[TBL] [Abstract][Full Text] [Related]
13. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets.
Schober A; Zernecke A; Liehn EA; von Hundelshausen P; Knarren S; Kuziel WA; Weber C
Circ Res; 2004 Nov; 95(11):1125-33. PubMed ID: 15528472
[TBL] [Abstract][Full Text] [Related]
14. Chemokines in cutaneous wound healing.
Gillitzer R; Goebeler M
J Leukoc Biol; 2001 Apr; 69(4):513-21. PubMed ID: 11310836
[TBL] [Abstract][Full Text] [Related]
15. Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis.
Tanuma N; Sakuma H; Sasaki A; Matsumoto Y
Acta Neuropathol; 2006 Aug; 112(2):195-204. PubMed ID: 16733654
[TBL] [Abstract][Full Text] [Related]
16. Chemokines in vascular dysfunction and remodeling.
Schober A
Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1950-9. PubMed ID: 18818421
[TBL] [Abstract][Full Text] [Related]
17. Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks.
Semple BD; Kossmann T; Morganti-Kossmann MC
J Cereb Blood Flow Metab; 2010 Mar; 30(3):459-73. PubMed ID: 19904283
[TBL] [Abstract][Full Text] [Related]
18. Chemokines in the MPTP model of Parkinson's disease: absence of CCL2 and its receptor CCR2 does not protect against striatal neurodegeneration.
Kalkonde YV; Morgan WW; Sigala J; Maffi SK; Condello C; Kuziel W; Ahuja SS; Ahuja SK
Brain Res; 2007 Jan; 1128(1):1-11. PubMed ID: 17126305
[TBL] [Abstract][Full Text] [Related]
19. Expression of chemokine and receptors in Lewis rats with experimental autoimmune anterior uveitis.
Fang IM; Yang CH; Lin CP; Yang CM; Chen MS
Exp Eye Res; 2004 Jun; 78(6):1043-55. PubMed ID: 15109911
[TBL] [Abstract][Full Text] [Related]
20. Leishmania major modulates chemokine and chemokine receptor expression by dendritic cells and affects their migratory capacity.
Steigerwald M; Moll H
Infect Immun; 2005 Apr; 73(4):2564-7. PubMed ID: 15784607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
